| Tretinoin | Approved Investigational Nutraceutical | AQP3 | 360 |
downregulated | Tretinoin results in decreased expression of AQP3 mRNA | 9p13.3 | |
| Tretinoin | Approved Investigational Nutraceutical | AQP9 | 366 |
upregulated | Tretinoin results in increased expression of AQP9 mRNA | 15q21.3 | |
| Tretinoin | Approved Investigational Nutraceutical | AR | 367 |
downregulated | Tretinoin results in decreased expression of AR mRNA | Xq12 | |
| Tretinoin | Approved Investigational Nutraceutical | ARAP3 | 64411 |
downregulated | Tretinoin results in decreased expression of ARAP3 mRNA | 5q31.3 | |
| Tretinoin | Approved Investigational Nutraceutical | ARC | 23237 |
downregulated | Tretinoin results in decreased expression of ARC mRNA | 8q24.3 | |
| Tretinoin | Approved Investigational Nutraceutical | AREG | 374 |
upregulated | Tretinoin results in increased expression of AREG mRNA | 4q13.3 | |
| Tretinoin | Approved Investigational Nutraceutical | ARF1 | 375 |
downregulated | Tretinoin results in decreased expression of ARF1 mRNA | 1q42.13 | |
| Tretinoin | Approved Investigational Nutraceutical | ARFGEF3 | 57221 |
downregulated | Tretinoin results in decreased expression of ARFGEF3 mRNA | 6q23.3-q24.1 | |
| Tretinoin | Approved Investigational Nutraceutical | ARGLU1 | 55082 |
downregulated | Tretinoin results in decreased expression of ARGLU1 mRNA | 13q33.3 | |
| Tretinoin | Approved Investigational Nutraceutical | ARHGAP18 | 93663 |
downregulated | Tretinoin results in decreased expression of ARHGAP18 mRNA | 6q22.33 | |
| Tretinoin | Approved Investigational Nutraceutical | ARHGAP20 | 57569 |
upregulated | Tretinoin results in increased expression of ARHGAP20 mRNA | 11q22.3-q23.1 | |
| Tretinoin | Approved Investigational Nutraceutical | ARHGAP22 | 58504 |
downregulated | Tretinoin results in decreased expression of ARHGAP22 mRNA | 10q11.22-q11.23 | |
| Tretinoin | Approved Investigational Nutraceutical | ARHGAP24 | 83478 |
upregulated | Tretinoin results in increased expression of ARHGAP24 mRNA | 4q21.23-q21.3 | |
| Tretinoin | Approved Investigational Nutraceutical | ARHGAP25 | 9938 |
downregulated | Tretinoin results in decreased expression of ARHGAP25 mRNA | 2p13.3 | |
| Tretinoin | Approved Investigational Nutraceutical | ARHGAP28 | 79822 |
upregulated | Tretinoin results in increased expression of ARHGAP28 mRNA | 18p11.31 | |
| Tretinoin | Approved Investigational Nutraceutical | ARHGAP36 | 158763 |
downregulated | Tretinoin results in decreased expression of ARHGAP36 mRNA | Xq26.1 | |
| Tretinoin | Approved Investigational Nutraceutical | ARHGAP4 | 393 |
upregulated | Tretinoin results in increased expression of ARHGAP4 mRNA | Xq28 | |
| Tretinoin | Approved Investigational Nutraceutical | ARHGAP45 | 23526 |
upregulated | Tretinoin results in increased expression of ARHGAP45 mRNA | 19p13.3 | |
| Tretinoin | Approved Investigational Nutraceutical | ARHGAP6 | 395 |
upregulated | Tretinoin results in increased expression of ARHGAP6 mRNA | Xp22.2 | |
| Tretinoin | Approved Investigational Nutraceutical | ARHGAP9 | 64333 |
upregulated | Tretinoin results in increased expression of ARHGAP9 mRNA | 12q13.3 | |
| Tretinoin | Approved Investigational Nutraceutical | ARHGDIA | 396 |
downregulated | Tretinoin results in decreased expression of ARHGDIA mRNA | 17q25.3 | |
| Tretinoin | Approved Investigational Nutraceutical | ARHGDIB | 397 |
upregulated | Tretinoin results in increased expression of ARHGDIB mRNA | 12p12.3 | |
| Tretinoin | Approved Investigational Nutraceutical | ARHGEF10L | 55160 |
upregulated | Tretinoin results in increased expression of ARHGEF10L mRNA | 1p36.13 | |
| Tretinoin | Approved Investigational Nutraceutical | ARHGEF16 | 27237 |
downregulated | Tretinoin results in decreased expression of ARHGEF16 mRNA | 1p36.32 | |
| Tretinoin | Approved Investigational Nutraceutical | ARHGEF2 | 9181 |
upregulated | Tretinoin results in increased expression of ARHGEF2 mRNA | 1q22 | |